Corporate News     13-May-19
Board of SIL Investments recommends Final Dividend
Of Rs.1.5 per share
SIL Investments announced that the Board of Directors of the Company at its meeting held on 10 May 2019, has recommended a Final dividend of Rs.1.5 per share (i.e.15%), subject to the approval of the shareholders.
Previous News
  SIL Investments reports standalone net loss of Rs 2.10 crore in the March 2021 quarter
 ( Results - Announcements 12-May-21   14:22 )
  SIL Investments to discuss results
 ( Corporate News - 03-May-24   17:20 )
  SIL Investments standalone net profit declines 43.40% in the June 2020 quarter
 ( Results - Announcements 06-Aug-20   14:44 )
  Board of SIL Investments recommends Final Dividend
 ( Corporate News - 12-May-21   16:48 )
  SIL Investments consolidated net profit declines 26.97% in the September 2023 quarter
 ( Results - Announcements 10-Nov-23   14:37 )
  SIL Investments fixes record date for dividend
 ( Market Beat - Reports 05-Jul-17   14:11 )
  SIL Investments reports consolidated net loss of Rs 1.91 crore in the March 2021 quarter
 ( Results - Announcements 12-May-21   14:44 )
  Ashish Chauhan ceases as company secretary & compliance officer of SIL Investments
 ( Corporate News - 03-Dec-12   15:47 )
  SIL Investments AGM scheduled
 ( Corporate News - 05-Aug-22   14:24 )
  SIL Investments fixes record date for final dividend
 ( Market Beat - Reports 30-Jul-19   14:42 )
  SIL Investments reports net profit of Rs 0.46 crore in the December 2009 quarter
 ( Results - Announcements 25-Jan-10   16:22 )
Other Stories
  LMW schedules board meeting
  03-Jul-25   09:15
  Julien Agro Infratech announces board meeting date
  03-Jul-25   09:15
  Alembic Pharmaceuticals announces acquisition of Utility Therapeutics
  03-Jul-25   09:15
  Shriram Asset Mgt. Company schedules AGM
  03-Jul-25   09:14
  Ideaforge Technology to convene AGM
  03-Jul-25   09:14
  D-Link (India) to announce Quarterly Result
  03-Jul-25   09:14
  Tuni Textile Mills to conduct board meeting
  03-Jul-25   09:14
  Biocon Biologics receives EU marketing authorisation for Vevzuo® and Evfraxy® biosimilars of Denosumab
  03-Jul-25   09:12
  Shakti Pumps launches QIP issue
  03-Jul-25   09:08
  Jai Mata Glass to conduct board meeting
  02-Jul-25   19:12
Back Top